48 related articles for article (PubMed ID: 11409876)
1. Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin.
Yeh PY; Chuang SE; Yeh KH; Song YC; Cheng AL
Biochem Biophys Res Commun; 2001 Jun; 284(4):880-6. PubMed ID: 11409876
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.
Yeh PY; Chuang SE; Yeh KH; Song YC; Chang LL; Cheng AL
Oncogene; 2004 Apr; 23(20):3580-8. PubMed ID: 15116093
[TBL] [Abstract][Full Text] [Related]
3. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.
Mandl M; Slack DN; Keyse SM
Mol Cell Biol; 2005 Mar; 25(5):1830-45. PubMed ID: 15713638
[TBL] [Abstract][Full Text] [Related]
4. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
[TBL] [Abstract][Full Text] [Related]
5. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
She QB; Ma WY; Dong Z
Oncogene; 2002 Feb; 21(10):1580-9. PubMed ID: 11896587
[TBL] [Abstract][Full Text] [Related]
6. SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.
Huang L; Gotoh N; Zhang S; Shibuya M; Yamamoto T; Tsuchida N
Biochem Biophys Res Commun; 2004 Nov; 324(3):1011-7. PubMed ID: 15485655
[TBL] [Abstract][Full Text] [Related]
7. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53.
Turenne GA; Paul P; Laflair L; Price BD
Oncogene; 2001 Aug; 20(37):5100-10. PubMed ID: 11526498
[TBL] [Abstract][Full Text] [Related]
8. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping and regulation of the association of p53 with p34cdc2.
Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
[TBL] [Abstract][Full Text] [Related]
10. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
[TBL] [Abstract][Full Text] [Related]
11. Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability.
Kim YY; Park BJ; Kim DJ; Kim WH; Kim S; Oh KS; Lim JY; Kim J; Park C; Park SI
FEBS Lett; 2004 Aug; 572(1-3):92-8. PubMed ID: 15304330
[TBL] [Abstract][Full Text] [Related]
12. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.
Blanco S; Klimcakova L; Vega FM; Lazo PA
FEBS J; 2006 Jun; 273(11):2487-504. PubMed ID: 16704422
[TBL] [Abstract][Full Text] [Related]
13. Cdk9 phosphorylates p53 on serine 392 independently of CKII.
Claudio PP; Cui J; Ghafouri M; Mariano C; White MK; Safak M; Sheffield JB; Giordano A; Khalili K; Amini S; Sawaya BE
J Cell Physiol; 2006 Sep; 208(3):602-12. PubMed ID: 16741955
[TBL] [Abstract][Full Text] [Related]
14. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
15. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53.
Chouinard N; Valerie K; Rouabhia M; Huot J
Biochem J; 2002 Jul; 365(Pt 1):133-45. PubMed ID: 12071847
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region.
Dang PM; Morel F; Gougerot-Pocidalo MA; El Benna J
Biochemistry; 2003 Apr; 42(15):4520-6. PubMed ID: 12693948
[TBL] [Abstract][Full Text] [Related]
17. Identification of sites of serine and threonine phosphorylation via site-directed mutagenesis--site transformation versus site elimination.
Kennelly PJ
Anal Biochem; 1994 Jun; 219(2):384-6. PubMed ID: 8080101
[No Abstract] [Full Text] [Related]
18. Identification of a cytoplasmic-retention sequence in ERK2.
Rubinfeld H; Hanoch T; Seger R
J Biol Chem; 1999 Oct; 274(43):30349-52. PubMed ID: 10521408
[TBL] [Abstract][Full Text] [Related]
19. p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK.
Marchetti A; Cecchinelli B; D'Angelo M; D'Orazi G; Crescenzi M; Sacchi A; Soddu S
Cell Death Differ; 2004 Jun; 11(6):596-607. PubMed ID: 15150542
[TBL] [Abstract][Full Text] [Related]
20. Mutations in ERK2 binding sites affect nuclear entry.
Yazicioglu MN; Goad DL; Ranganathan A; Whitehurst AW; Goldsmith EJ; Cobb MH
J Biol Chem; 2007 Sep; 282(39):28759-28767. PubMed ID: 17656361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
